Benitec Biopharma authorizes 5M shares of preferred stock, effective Dec 9, 2024

Benitec Biopharma Inc.

Stockholders approved at Dec 4, 2024 annual meeting; amendment effective Dec 9, 2024.
Authorizes 5,000,000 shares of preferred stock, par value $0.0001, and corresponding increase in capital stock.
Amendment filed with Delaware Secretary of State; copy attached as Exhibit 3.1.
No specific use of proceeds or plan for issuance disclosed in the filing.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Benitec Biopharma Inc.: Amendment to Certificate of Incorporation to authorize 5,000,000 shares of preferred stock and corresponding change to authorized capital stock (effective 2024-12-09).

Change: charter amendment
Effective: 2024-12-09

Exact text from the filing

at the Company’s 2024 Annual Meeting of Stockholders held on December 4, 2024, the stockholders of the Company approved an amendment (the “Amendment”) to the Company’s Amended and Restated Certificate of Incorporation, as amended, to authorize the issuance of 5,000,000 shares of preferred stock, par value $0.0001, and to make a corresponding change to the number of authorized shares of capital stock.

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

Benitec Biopharma Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-274395

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.